Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
31.18
-0.25 (-0.8%)
BSENSE

Apr 02

BSE+NSE Vol: 349

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryParmax Pharma VS Pharmaceuticals & Biotechnology
 
1D
-0.8%
0.25%
1W
12.36%
-2.6%
1M
-5.43%
-8.62%
YTD
-7.83%
-13.96%
1Y
-30.56%
-4.3%
3Y
2.7%
24.29%
5Y
-15.16%
46.55%
10Y
%
190.15%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.37%
0%
-7.37%
6 Months
2.23%
0%
2.23%
1 Year
-30.56%
0%
-30.56%
2 Years
7.89%
0%
7.89%
3 Years
2.7%
0%
2.7%
4 Years
-27.15%
0%
-27.15%
5 Years
-15.16%
0%
-15.16%

Parmax Pharma for the last several years.

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Industry stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
Return Quartiles - by Market Cap stock-summary
Icon
Not enough Stock Price history for Quartile Analysis
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available